← FDA DRUG APPROVALS

FDA ANDA · ANDA088484

MEDROXYPROGESTERONE ACETATE

Sponsor: UPSHER SMITH LABS

APPLICATION
ANDA088484
TYPE
ANDA
ORIGINAL APPROVAL
1984-07-26
LATEST ACTION
1998-12-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

MEDROXYPROGESTERONE ACETATEDiscontinued
MEDROXYPROGESTERONE ACETATE 10MG · TABLET · ORAL

Approval history

1998-12-01Manufacturing (CMC) · Supplement 33AP
1995-10-18Manufacturing (CMC) · Supplement 31AP
1995-09-11Manufacturing (CMC) · Supplement 32AP
1995-03-28Labeling · Supplement 30AP
1992-09-10Labeling · Supplement 29AP
1992-06-19Labeling · Supplement 28AP
1991-03-15Labeling · Supplement 27AP
1991-03-15Labeling · Supplement 34AP
1989-08-04Labeling · Supplement 25AP
1989-06-27Labeling · Supplement 24AP
1989-03-15Labeling · Supplement 23AP
1988-06-16Manufacturing (CMC) · Supplement 22AP
1988-04-06Manufacturing (CMC) · Supplement 19AP
1988-04-06Manufacturing (CMC) · Supplement 21AP
1988-04-06Manufacturing (CMC) · Supplement 20AP
1986-07-09Manufacturing (CMC) · Supplement 16AP
1986-03-20Manufacturing (CMC) · Supplement 14AP
1985-10-16Manufacturing (CMC) · Supplement 13AP
1985-08-14Manufacturing (CMC) · Supplement 9AP
1985-08-14Manufacturing (CMC) · Supplement 5AP
1985-08-14Manufacturing (CMC) · Supplement 1AP
1985-08-14Manufacturing (CMC) · Supplement 6AP
1985-08-14Manufacturing (CMC) · Supplement 10AP
1985-06-14Manufacturing (CMC) · Supplement 12AP
1985-02-27Manufacturing (CMC) · Supplement 3AP
1985-02-27Manufacturing (CMC) · Supplement 8AP
1985-02-27Manufacturing (CMC) · Supplement 4AP
1985-02-27Manufacturing (CMC) · Supplement 2AP
1984-07-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →